GLP-1 receptor agonist therapy should be considered in all patients with type II diabetes and elevated ASCVD risk regardless of A1c or current hyperglycemic therapy
Reference Kim H, Song Z, Zhang R, Davies BSJ, Zhang K
In the UK, prediabetes is defined by an HbA1c (a measure of your average blood sugar over 2 to 3 months) between 42 and 47 mmol/mol (6.0 to 6.4%), or a fasting plasma glucose between 5.5 and 6.9 mmol/L
PMC / Int J Mol Sci
[TAKE ACTION: Ask Your Lawmakers to Reverse the GLP-1 Coverage Change ] Share Your Story MOAAs advocacy relies on the testimony and experiences of servicemembers and families impacted by changes to TRICARE policy
Helps support improved glucose management in type 2 diabetes By modulating GLP-1 pathways, WEGOVY 0.25MG INJECTION aids in stabilizing glucose levels, making it helpful for adults who need added support alongside diet and physical activity